Health

Mandy Kloppers

Mental Health Awareness Week: Three-quarters of Joint Pain Sufferers Have Experienced Anxiety or Depression

Expert Advice to Help Prioritise your Mental and Emotional Well-being

New survey insights have revealed the stark reality of living with persistent joint pain, with almost half (43%) of sufferers saying it’s taken a toll on their mental health.[i]

Whilst the physical implications of joint pain can be obvious, research commissioned by GOPO® Joint Health – a leading joint health supplement proven to reduce pain, stiffness and improve mobility – indicates that prolonged pain and discomfort can also have a significant effect on a person’s mental and emotional health. In fact, almost three-quarters (73%) of joint pain sufferers have experienced anxiety or depression as a result of their pain.i

Consultant rheumatologist, Dr Rod Hughes, comments: “Whilst conditions such as arthritis are typically associated with chronic joint pain, it’s not uncommon for pain to be present without a diagnosed joint health condition. Age, hormones and injuries can all play a part in causing discomfort, with women experiencing joint issues more severely than men.[ii] The impact of joint pain often goes beyond a person’s physical limitations and also has a profound effect on their emotional and mental well-being.”

Musculoskeletal conditions affect over 17 million people across the UK,[iii] with pain as one of the leading symptoms. As a result, sufferers most commonly report feelings of exhaustion (48%), stress (41%) and anger (36%).i

 

Multiple studies show that people who experience more negative emotions also report more pain, indicating that the two are intrinsically linked. [iv] To help manage the mental and emotional burden of joint pain, and avoid exacerbating symptoms further, it’s important that people develop coping strategies.

 

Dr Rod Hughes suggests: Living with joint pain can be mentally and emotionally challenging, with almost 1 in 4 (22%) sufferers feeling overwhelmed and unable to cope.iii To help support your emotional and mental well-being try relaxation techniques, mindfulness and other forms or meditation. Whilst it won’t reduce the pain you experience; it may help you better approach and manage it.

As well as this, talk to your support network. Whether it’s friends, family or support forums it’s important to talk about how you’re feeling, and the effect joint pain is having on your life. Sharing your experience can help those around you better understand the challenges you face and provides a way for you to communicate how best they can support you.”

Alongside strategies which support your mental and emotional well-being, it’s important to find the right treatment to lesson symptoms and improve quality of life. Whilst medication can help to alleviate joint pain, long-term use of analgesics and nonsteroidal anti-inflammatory drugs (NSAIDs) may put users at risk of adverse side effects. For example, constipation and headaches can occur with some analgesics, and indigestion and peptic ulceration with NSAIDs.[v]

Dr Rod Hughes says: “Chronic or persistent joint pain can impact all aspects of life, affecting your ability to work, sleep, socialise and take care of yourself. These lifestyle constraints can lead people to look for quick-fix ways to alleviate pain, such as the use of painkillers. While analgesics can be effective for the short-term relief of mild to moderate pain, long-term use carries a level of associated risk. According to GOPO’s survey, over half (56%) of those currently using painkillers or prescribed medication to manage their joint pain would prefer to use lifestyle changes alongside complimentary supplements.i

One such option could be the galactolipid GOPO, which has been shown in randomized, placebo controlled clinical trials to significantly reduce arthritis joint pain and reduce consumption of paracetamol by 40%.[vi] In vitro studies have demonstrated GOPO has anti-inflammatory properties which have a protective effect on cartilage, potentially even helping cartilage and joint tissues to rebuild and regenerate. GOPO was found to have a positive safety profile and can be taken long-term.”

Extensive studies involving over 400 patients with chronic pain conditions, such as osteoarthritis, have shown that GOPO® produces significant and consistent pain relief and improved joint function. In one study, 8 out of 10 patients reported a significant reduction in pain after just 3 weeks of GOPO®.[vii]

GOPO® Joint Health is available from Boots, Amazon, Tesco, Holland and Barrett, and independent chemists and retailers nationwide. Visit www.gopo.co.uk for further information.

 

 

GOPO® Joint Health 

High levels of the galactolipid GOPO® are found only in GOPO® Joint Health. GOPO® has been evaluated in numerous rigorously conducted, placebo-controlled, clinical trials involving hundreds of patients with difficult-to-treat chronic joint conditions, including osteoarthritis and rheumatoid arthritis.[i],xii[ii] Efficacy results have been consistently positive and evidence supporting the benefits of GOPO® has been presented around the world at numerous clinical meetings and many studies have been published in peer-reviewed journals.

HOW THE GALACTOLIPID, GOPO®, WORKS

Laboratory studies into GOPO® have demonstrated that it can switch off certain genes responsible for producing proteins and enzymes that have been implicated in inflammatory joint destruction and switch on genes that help to produce collagen and cartilage, which are essential components of a healthy joint. This suggests that when taken long term, the galactolipid GOPO® may protect cartilage cells.[iii]

GOPO® Joint Health is also rich in Vitamin C which is essential for normal collagen formation, needed by the body for healthy bones and cartilage.

GOPO® Joint Health is priced at £38.99 for 200 capsules. Visit www.gopo.co.uk for further information.

 

GOPO® Joint Health Awards

Shortlisted in the ‘Joints & Muscular Pain’ category, MVP Awards 2023 – P3 Pharmacy, Pharmacy and Training Matters.

Winner of the ‘Assistant’s Choice’ award, Pharmacy Product of the Year 2022 – Independent Community Pharmacist magazine.

Photo by Towfiqu barbhuiya on Unsplash


[i] Rein E, Kharazmi A, Winther K. A herbal remedy, Hyben Vital (stand. Powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with OA – a double-blind, placebo-controlled, randomised trial. Phytomedicine 2004.

[ii] Christensen R et al.  Does the hip powder of Rose canina (rosehip) reduce pain in osteoarthritis patients? – a meta-analysis of randomised controlled trials, Osteoarthritis Cartilage (2008)

[iii] Schwager J, Richard N, Wolfram S. Anti-inflammatory and chondro-protective effects of rosehip powder and its constituent galactolipids GOPO Poster presentation at the World Congress of Osteoarthritis (OARSI) 2008



[i] GOPO® Joint Health survey on 2,001 joint pain sufferers in the UK. November 2023.

[ii] NICE. 2023. Osteoarthritis. What are the Risk Factors? Available at: https://cks.nice.org.uk/topics/osteoarthritis/background-information/risk-factors/

[iii] UK Health Security Agency. Why are musculoskeletal conditions the biggest contributor to morbidity? 2019

Available at: https://ukhsa.blog.gov.uk/2019/03/11/why-are-musculoskeletal-conditions-the-biggest-contributor-to-morbidity/ (Accessed: December 2023).

[iv] Arthritis Foundation. The Emotion-Pain Connection. No date. Available at: https://www.arthritis.org/health-wellness/healthy-living/emotional-well-being/emotional-self-care/the-emotion-pain-connection (Accesssed: December 2023).

[v] NHS. NSAIDS. No date. Available at: https://www.nhs.uk/conditions/nsaids/ (Accessed: December 2023).

[vi] Winther, K et al. “A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial.” Scandinavian journal of rheumatology vol. 34,4 (2005)

[vii] Winther, K et al. “A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial.” Scandinavian journal of rheumatology vol. 34,4 (2005)

[viii] Rein E, Kharazmi A, Winther K. A herbal remedy, Hyben Vital (stand. Powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with OA – a double-blind, placebo-controlled, randomised trial. Phytomedicine 2004.

[ix] Christensen R et al.  Does the hip powder of Rose canina (rosehip) reduce pain in osteoarthritis patients? – a meta-analysis of randomised controlled trials, Osteoarthritis Cartilage (2008)

[x] Schwager J, Richard N, Wolfram S. Anti-inflammatory and chondro-protective effects of rosehip powder and its constituent galactolipids GOPO Poster presentation at the World Congress of Osteoarthritis (OARSI) 2008


Leave a Comment

Your email address will not be published. Required fields are marked *